Literature DB >> 11469865

Solution structure of the third immunoglobulin domain of the neural cell adhesion molecule N-CAM: can solution studies define the mechanism of homophilic binding?

A R Atkins1, J Chung, S Deechongkit, E B Little, G M Edelman, P E Wright, B A Cunningham, H J Dyson.   

Abstract

Homophilic binding of the neural cell adhesion molecule (N-CAM) mediates the calcium-independent cell-cell adhesion that is involved in neuronal development. Two hypotheses have been advanced for the mechanism of homophilic binding. Cell-based experiments have implicated each of the five extracellular immunoglobulin (Ig) domains of N-CAM in the homophilic adhesion interaction, and have predicted that the third domain (Ig III) self-associates. The alternative hypothesis is based on solution observations, which implicate a specific antiparallel interaction between the first two Ig domains (Ig I and Ig II). In order to test these hypotheses, we have determined a high-resolution solution structure of recombinant Ig III (sequence derived from chicken N-CAM) and examined the aggregation behavior of isolated Ig domains in solution. The structure shows that Ig III adopts a canonical Ig fold, in which the beta strands ABED and A'GFCC' form two beta sheets that are linked by a disulfide bond. In contrast to the demonstrated aggregation of Ig III on solid supports, we were unable to demonstrate self-association of Ig III under any of a variety of solution conditions. The structure shows that the surface of Ig III is dominated by two large acidic patches, which may explain our failure to observe self-association in solution. To evaluate the involvement of the Ig I-Ig II interaction in cell-cell adhesion, we designed a point mutation in Ig I (F19S) that proved sufficient to abrogate the Ig I-Ig II interaction seen in solution. However, the introduction of this mutation into full-length N-CAM expressed in COS-7 cells failed to affect N-CAM-mediated cell-cell adhesion. The inability to observe Ig III self-association in solution, combined with the failure of the F19S mutation to affect N-CAM-mediated cell-cell adhesion, suggests that, although solution studies can give important insights into the structures of individual domains, the interactions observed in solution between the domains may not be representative of the interactions that occur on the cell surface. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469865     DOI: 10.1006/jmbi.2001.4861

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Structure and mutagenesis of neural cell adhesion molecule domains: evidence for flexibility in the placement of polysialic acid attachment sites.

Authors:  Deirdre A Foley; Kristin G Swartzentruber; Arnon Lavie; Karen J Colley
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

Review 2.  Intracellular signaling by the neural cell adhesion molecule.

Authors:  Gro Klitgaard Povlsen; Dorte Kornerup Ditlevsen; Vladimir Berezin; Elisabeth Bock
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  Mechanism of homophilic adhesion by the neural cell adhesion molecule: use of multiple domains and flexibility.

Authors:  C P Johnson; I Fujimoto; C Perrin-Tricaud; U Rutishauser; D Leckband
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

4.  Elasticity and rupture of a multi-domain neural cell adhesion molecule complex.

Authors:  Venkat Maruthamuthu; Klaus Schulten; Deborah Leckband
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

5.  Role of glial cell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF.

Authors:  Janne Nielsen; Kamil Gotfryd; Shizhong Li; Nikolaj Kulahin; Vladislav Soroka; Kim K Rasmussen; Elisabeth Bock; Vladimir Berezin
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.